Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Colorcon
Merck
Medtronic
Dow

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018063

See Plans and Pricing

« Back to Dashboard

NDA 018063 describes CORGARD, which is a drug marketed by Us Worldmeds Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the CORGARD profile page.

The generic ingredient in CORGARD is nadolol. There are five drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the nadolol profile page.
Summary for 018063
Tradename:CORGARD
Applicant:Us Worldmeds Llc
Ingredient:nadolol
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018063
Mechanism of ActionAdrenergic beta-Antagonists
Medical Subject Heading (MeSH) Categories for 018063
Suppliers and Packaging for NDA: 018063
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CORGARD nadolol TABLET;ORAL 018063 NDA US WorldMeds, LLC 27505-100 27505-100-01 100 TABLET in 1 BOTTLE (27505-100-01)
CORGARD nadolol TABLET;ORAL 018063 NDA US WorldMeds, LLC 27505-101 27505-101-01 100 TABLET in 1 BOTTLE (27505-101-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength80MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength120MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 018063

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Baxter
Colorcon
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.